Workflow
Genmab to buy Dutch cancer drugmaker Merus for $8 billion
GenmabGenmab(US:GMAB) Reutersยท2025-09-29 05:19

Group 1 - Genmab has agreed to acquire Merus NV for $8 billion in cash [1] - Merus NV is a Nasdaq-listed Dutch biotech firm focused on developing a head-and-neck cancer drug [1]